Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
Phosphorylated α-synuclein accounts for more than 90% of α-synuclein found in Lewy bodies of Parkinson’s disease (PD). We aimed to examine whether plasma Ser129-phosphorylated α-synuclein (pS129-α-synuclein) is a surrogate marker of PD progression. This...
Main Authors: | Chin-Hsien Lin, Huei-Chun Liu, Shieh-Yueh Yang, Kai-Chien Yang, Chau-Chung Wu, Ming-Jang Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/10/1601 |
Similar Items
-
CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
by: Xiaobing Qing, et al.
Published: (2017-10-01) -
Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease
by: Jiaolong Yang, et al.
Published: (2021-01-01) -
Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
by: Huang Yue, et al.
Published: (2012-01-01) -
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
by: Chen Tian, et al.
Published: (2019-05-01) -
Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
by: Zhipeng Wang, et al.
Published: (2019-07-01)